MET
MetLife, Inc.
Set alert
- YTD
- +26.70%
- 1 year
- +26.35%
- Open
- 101.60
- Prev close
- 100.83
- Mkt cap
- 63.56B
- Vol
- 4.03M
- Avg vol
- 3.18M
- EPS
- 5.22
- P/E
- 19.16
- Div yield
- 2.35%
More statistics
- Low
- 99.70
- High
- 101.67
- Forward P/E
- 8.96
- Beta
- 0.78
- Short ratio
- 3.29
- Inst. own
- 78.30%
- Dividend
- 2.37
- Ex-div date
- Nov 2, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 97.55
- 200-d avg
- 85.58
- 1y target
- 107.63
Key statistics
- Market cap
- 63.56B
- Enterprise value
- 87.59B
- Trailing P/E
- 19.16
- Forward P/E
- 8.96
- PEG ratio
- 0.53
- Price / sales
- 0.80
- Price / book
- 2.32
- EPS (TTM)
- 5.22
- Beta
- 0.78
- Dividend yield
- 2.35%
- Payout ratio
- 43.97%
- Profit margin
- 4.57%
- Revenue (TTM)
- 79.40B
- Revenue growth
- 10.50%
- Free cash flow
- -20.95B
- Total cash
- 27.32B
- Total debt
- 50.31B
- Return on equity
- 13.09%
- Shares outstanding
- 635.48M
- Short % of float
- 1.70%
- 50-day average
- 97.55
- 200-day average
- 85.58
Analyst view
Consensus: buy
- Target (low)
- 84.00
- Target (mean)
- 107.63
- Target (high)
- 119.00
- Strong buy5
- Buy8
- Hold4
- Sell0
- Strong sell1
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 2.77.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 2.77 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 2.30 | 2.43 | +0.13 | +5.65% |
| May 6, 2026 | Mar 31, 2026 | 2.27 | 2.42 | +0.15 | +6.61% |
| Feb 4, 2026 | Dec 31, 2025 | 2.34 | 2.58 | +0.24 | +10.26% |
| Nov 5, 2025 | Sep 30, 2025 | 2.31 | 2.34 | +0.03 | +1.30% |
| Aug 6, 2025 | Jun 30, 2025 | 2.15 | 2.02 | -0.13 | -6.05% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | main | Buy | Buy |
| Oct 15, 2026 | JP Morgan | main | Overweight | Overweight |
| Oct 12, 2026 | Wells Fargo | main | Overweight | Overweight |
| Oct 7, 2026 | Mizuho | main | Outperform | Outperform |
| Oct 7, 2026 | Barclays | main | Overweight | Overweight |
| Oct 6, 2026 | UBS | main | Buy | Buy |
About MetLife, Inc.
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Insurance - Life
- Country
- United States
- Website
- metlife.com
News
- Can MetLife Deliver a Q3 Earnings Beat on Strong Segment Growth?
- Seeking Clues to MetLife (MET) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
- MetLife CEO and CFO to Speak at the J.P. Morgan Financials Conference
- 5 Overlooked Blue-Chip High-Yield Dividend Stocks to Buy in November
- MetLife, Inc. $MET Stock Purchased by Citizens Financial Group Inc. RI
- RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
- MetLife, Inc. $MET Stock Sold by Axxcess Wealth Management LLC
- MetLife: Momentum Into Q3 Earnings, Big Technical Breakout Too
- Why Investors Need to Take Advantage of These 2 Finance Stocks Now
- TD Cowen Maintains Buy on MetLife, Raises Price Target to $114
Your note
Sign in to keep a note on MET — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DEBEL MARLENE | Officer | Sale | May 31, 2026 | 154,380 |
| GRISE CHERYL W | Director | Stock Award(Grant) | Jun 9, 2025 | 88,785 |
| GUTIERREZ CARLOS M. | Director | Stock Award(Grant) | Mar 31, 2026 | 44,552 |
| HUBBARD ROBERT GLENN | Director | Stock Award(Grant) | Sep 30, 2026 | 109,132 |
| KELLY EDWARD J. III | Director | Stock Award(Grant) | Jun 9, 2025 | 37,112 |
| KENNARD WILLIAM E | Director | Stock Award(Grant) | Sep 30, 2026 | 48,258 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.05% | 51,786,925 | 5.18B | Jun 29, 2026 |
| Dodge & Cox Inc. | 7.53% | 48,431,150 | 4.84B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 5.51% | 35,483,789 | 3.55B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.67% | 30,031,431 | 3.00B | Jun 29, 2026 |
| State Street Corporation | 3.94% | 25,336,999 | 2.53B | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 3.31% | 21,284,689 | 2.13B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 5.38% | 34,628,342 | 3.46B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.70% | 17,364,674 | 1.74B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.18% | 14,003,804 | 1.40B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 1.84% | 11,850,844 | 1.19B | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.11% | 7,112,401 | 711.38M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.09% | 7,016,008 | 701.74M | Aug 30, 2026 |